Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Pathology and Translational Medicine|May 17, 2023
Clinicopathologic characterization of cervical metastasis from an unknown primary tumor: a multicenter study in KoreaMiseon Lee, Uiree Jo, Joon Seon Song, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Desmethyl macrolides: synthesis and evaluation of 4-desmethyl telithromycinIan Glassford, Miseon Lee, Bharat Wagh, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 13, 2017
ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancerIn Hye Song, Young-Ae Kim, Sun-Hee Heo, et al.
Cancer Research and Treatment|March 8, 2018
Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related MarkersMiseon Lee, In Hye Song, Sun-Hee Heo, et al.
Journal of Advanced Research|April 11, 2025
ARHGEF3 coordinates adipocyte hypertrophy and differentiation through dual YAP-RhoA and PPARγ activationSana Abdul Khaliq, Shi-Young Park, Syeda Maham, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 30, 2018
Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasisMiseon Lee, Sun-Hee Heo, In Hye Song, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 8, 2025
APOBEC-Driven Hypermutation in the Lymphocyte-Predominant Group of Triple-Negative Breast CancerMiseon Lee, Ahwon Lee, Tae-Kyung Yoo, et al.
Journal of Cell Science|April 4, 2014
Multisite phosphorylation of C-Nap1 releases it from Cep135 to trigger centrosome disjunctionTara Hardy, Miseon Lee, Rebecca S Hames, et al.
Organic Letters|April 4, 2022
Copper Catalyzed Regioselective and Stereospecific Aziridine Opening with Pyridyl Grignard NucleophilesJaehee Lee, Xuan Ju, Miseon Lee, et al.
Plos One|August 18, 2017
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signalingIn Ah Park, Seong-Hye Hwang, In Hye Song, et al.
Pageof 6